Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 208

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

Open access
Tsilidis, K K, Allen, N E, Key, T J, Dossus, L, Lukanova, A, Bakken, K, Lund, E, Fournier, A, Overvad, K, Hansen, L, Tjønneland, A, Fedirko, V, Rinaldi, S, Romieu, I, Clavel-Chapelon, F, Engel, P, Kaaks, R, Schütze, M, Steffen, A, Bamia, C, Trichopoulou, A, Zylis, D, Masala, G, Pala, V, Galasso, R, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, H B, van Duijnhoven, F J B, Braem, M G M, Onland-Moret, N C, Gram, I T, Rodríguez, L, Travier, N, Sánchez, M-J, Huerta, J M, Ardanaz, E, Larrañaga, N, Jirström, K, Manjer, J, Idahl, A, Ohlson, N, Khaw, K-T, Wareham, N, Mouw, T, Norat, T, Riboli, E · 2011 · British Journal of Cancer

Abstract

BACKGROUND: It is well established that parity and use of oral contraceptives reduce the risk of ovarian cancer, but the associations with other reproductive variables are less clear. METHODS: We examined the associations of oral contraceptive use and reproductive factors with ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 327,396 eligible women, 878 developed ovarian cancer over an average of 9 years. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard models stratified by centre and age, and adjusted for smoking status, body mass index, unilateral ovariectomy, simple hysterectomy, menopausal hormone therapy, and mutually adjusted for age at menarche, age at menopause, number of full-term pregnancies and duration of oral contraceptive use. RESULTS: Women who used oral contraceptives for 10 or more years had a significant 45% (HR, 0.55; 95% CI, 0.41-0.75) lower risk compared with users of 1 year or less (P-trend, <0.01). Compared with nulliparous women, parous women had a 29% (HR, 0.71; 95% CI, 0.59-0.87) lower risk, with an 8% reduction in risk for each additional pregnancy. A high age at menopause was associated with a higher risk of ovarian cancer (>52 vs ≤ 45 years: HR, 1.46; 95% CI, 1.06-1.99; P-trend, 0.02). Age at menarche, age at first full-term pregnancy, incomplete pregnancies and breastfeeding were not associated with risk. CONCLUSION: This study shows a strong protective association of oral contraceptives and parity with ovarian cancer risk, a higher risk with a late age at menopause, and no association with other reproductive factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.2011.371

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Tsilidis, K. K., Allen, N. E., Key, T. J., Dossus, L., Lukanova, A., Bakken, K., Lund, E., Fournier, A., Overvad, K., Hansen, L., Tjønneland, A., Fedirko, V, Rinaldi, S., Romieu, I., Clavel-Chapelon, F., Engel, P., Kaaks, R., Schütze, M., Steffen, A., Bamia, C., Trichopoulou, A., Zylis, D., Masala, G., Pala, V, Galasso, R., Tumino, R., Sacerdote, C., Bueno-de-Mesquita, H. B., van Duijnhoven, F. J. B., Braem, M. G. M., Onland-Moret, N. C., Gram, I. T., Rodríguez, L., Travier, N., Sánchez, M.-J., Huerta, J. M., Ardanaz, E., Larrañaga, N., Jirström, K., Manjer, J., Idahl, A., Ohlson, N., Khaw, K.-T., Wareham, N., Mouw, T., Norat, T., & Riboli, E.
Venue
British Journal of Cancer
Published
2011-09-13
Volume
105
Issue
9
Pages
1436-1442
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2040686951
Cited by
208
References
2
FWCI
6.07
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.